Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOXANTRONE vs MOLNUPIRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITOXANTRONE vs MOLNUPIRAVIR: Safety Overview

Metric MITOXANTRONE MOLNUPIRAVIR
Total FAERS Reports 4,166 4,788
Deaths Reported 995 424
Death Rate 23.9% 8.9%
Hospitalizations 1,556 802
Average Patient Age 37.0 yrs 71.1 yrs
% Female Patients 48.0% 54.9%
FDA Approval Date Apr 11, 2006 N/A
Manufacturer Meitheal Pharmaceuticals Inc. Merck Sharp & Dohme LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued N/A